Publication:
Acute phase results from storm, a multicountry observational study of bipolar disorder treatment and outcomes

Placeholder

Organizational Units

Authors

Akkaya, Cengiz

Authors

Treuer, Tamás
Orûc, Lilijana
Loza, Nasser
El Saidi, Mohammed A.
Kovacs, Zoltán
Gülseren, Şeref Abdurrahman
Saylan, Mete I.
Colman, Samuel A.
Harrison, Gavan A.

Advisor

Language

Publisher:

Medicinska Naklada

Journal Title

Journal ISSN

Volume Title

Abstract

Objectives: This prospective observational study examined the outcomes associated with the treatment of bipolar mania in clinical practice settings in a diverse range of countries: Bosnia, Slovenia, Slovakia, Egypt, Saudi Arabia and Turkey. Particular emphasis was placed on investigating outcomes associated with treatment regimens including and excluding the atypical antipsychotic olanzapine. Subjects and Methods: In- and outpatients initiating or changing oral medication for the treatment of bipolar mania were grouped into two treatment cohorts: (1) olanzapine (N=569), and (2) non-olanzapine (N=325). Clinical outcome measures included change in Clinical Global Impressions-Bipolar Version Severity of Illness scale (CGI-BP), Young Mania Rating Scale (YAMS) and Hamilton Depression Rating scale-5 item (HAMD-5) scores, and response and remission rates. Outcomes were analysed by conventional linear or logistic regression, adjusted for potential confounders, using last observation carried forward (LOCF) at endpoint, and a marginal structural model (MSAI) approach to account for treatment switching. Results from the 12-week acute phase are presented. Results: Clinical improvements were observed in both cohorts. While no marked differences were apparent between the groups in adjusted mean baseline to LOCF endpoint change, longitudinal analysis of these variables using MSM averaged over all visits indicated greater improvements in the olanzapine versus non-olanzapine cohort in CGI-BP Overall (-0.26, p<.001), CGI-BP Mania (-0.19, p<.001), CGI-BP Depression (-0.10, p=.003), CGI Psychosis (-0.14, p=.001), YAMS (-1.70, p<.001), and HAMD-5 (-0.40, p<.001) scores. Conclusions: Inclusion of olanzapine after initiating or switching treatment for bipolar mania appeared to be beneficial during treatment in terms of symptom improvement.

Description

Bu çalışma, 09-13 Temmuz 2006 tarihlerinde Chicago[ABD] düzenlenen 25. Congress of the Collegium-Internationale-Neuro-Psychopharmacologicum (CINP)/29th Annual Meeting of the Canadian-College-of-Neuropsychopharmacology Kongresi‘nde bildiri olarak sunulmuştur.

Source:

Keywords:

Keywords

Antipsychotic, STORM, Bipolar disorder, Observational study, Mania, Olanzapine, Olanzapine, Antipsychotics, Mania, Schizophrenia, Scale, Psychiatry

Citation

Akkaya, C. vd. (2007). "Acute phase results from storm, a multicountry observational study of bipolar disorder treatment and outcomes". Psychiatria Danubina, 25. Congress of the Collegium-Internationale-Neuro-Psychopharmacologicum (CINP)/29th Annual Meeting of the Canadian-College-of-Neuropsychopharmacology, 19(4), 282-295.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads